Stem Cell Therapy for COVID-19 and Other Respiratory Diseases: Global Trends of Clinical Trials

26/08/2023
  • icon
  • icon
  • icon

Submit a Manuscript: https://www.f6publishing.com
World J Stem Cells 2020 June 26; 12(6): 471-480
DOI: 10.4252/wjsc.v12.i6.471
ISSN 1948-0210 (online)

MINIREVIEWS

Stem cell therapy for  COVID-19 and other respiratory diseases: Global trends of clinical trials

Hong-Long Ji, Cong Liu, Run-Zhen Zhao

7. Exosome therapy for respiratory disease
  • icon
  • icon
  • icon

Related articles

26/08/2023

7. Exosome therapy for respiratory disease

Early Prediction of COVID-19 Severity Using Extracellular Vesicle COPB2

View details

26/08/2023

3. Exosome therapy for immune diseases

Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases

View details

26/08/2023

6. Exosome therapy for kidney disease

Exosomal miRNA-19b-3p of Tubular Epithelial Cells Promotes M1 Macrophage Activation in Kidney Injury

View details

27/08/2023

6. The potential of MSCs in treating liver diseases

The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials

View details

27/08/2023

4. Stem cells in treating intervertebral disc degeneration

Application of stem cells in the repair of intervertebral disc degeneration

View details

26/08/2023

3. Exosome therapy for immune diseases

Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis

View details